Old Web
English
Sign In
Acemap
>
authorDetail
>
Ryousuke Fujita
Ryousuke Fujita
Tohoku Pharmaceutical University
Doxorubicin
Pharmacology
P-glycoprotein
K562 cells
Cytotoxicity
5
Papers
56
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide.
2001
Biological & Pharmaceutical Bulletin
Masaaki Ishikawa
Ryousuke Fujita
Shinobu Furusawa
Motoaki Takayanagi
Ken-ichi Sasaki
Susumu Satoh
Show All
Source
Cite
Save
Citations (2)
Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
2001
Biological & Pharmaceutical Bulletin
Yumi Kataoka
Masaaki Ishikawa
Masatomo Miura
Mitsuhiro Takeshita
Ryousuke Fujita
Shinobu Furusawa
Motoaki Takayanagi
Yoshio Takayanagi
Ken-ichi Sasaki
Show All
Source
Cite
Save
Citations (16)
Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole
2000
Biological & Pharmaceutical Bulletin
Masaaki Ishikawa
Ryousuke Fujita
Motoaki Takayanagi
Yoshio Takayanagi
Ken-ichi Sasaki
Show All
Source
Cite
Save
Citations (15)
Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine
2000
Methods and Findings in Experimental and Clinical Pharmacology
Ryousuke Fujita
Masaaki Ishikawa
Takayanagi M
Takayanagi Y
Ken-ichi Sasaki
Show All
Source
Cite
Save
Citations (15)
Reversal of Multidrug Resistance in Human Leukemia K562 by Tamolarizine, a Novel Calcium Antagonist
2000
Japanese Journal of Pharmacology
Norihisa Miyake
Ryousuke Fujita
Masaaki Ishikawa
Motoaki Takayanagi
Yoshio Takayanagi
Ken-ichi Sasaki
Show All
Source
Cite
Save
Citations (8)
1